Clinical Trials Directory

Trials / Completed

CompletedNCT02546258

Evaluation of the Performance of a Fungal Nail Treatment on the Visual Signs of Onychomycosis

A Prospective, Open Label, Non-comparative Clinical Investigation to Evaluate the Performance of a Fungal Nail Treatment on the Visual Signs of Onychomycosis

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Reckitt Benckiser Healthcare (UK) Limited · Industry
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

This is a prospective, open label, non-comparative clinical investigation to evaluate the performance of a Fungal Nail Treatment on the visual signs of onychomycosis. The Fungal Nail Treatment is a CE Marked Class I Medical Device and is commercially available as an over-the-counter product. The ability of the Fungal Nail Treatment to treat the visual signs of mild fungal toenail infections will be determined by a reduction in the surface area of the infection over time. This will be assessed through visual quantification of the infected area from baseline, as measured by image analysis, throughout the treatment period, where subjects will follow instructions for use on the product pack and self-treat for the duration of the investigation or until their condition has resolved. Both subject and podiatrist will assess the improvement of signs and symptoms of the target nail.

Conditions

Interventions

TypeNameDescription
DEVICEA Fungal Nail Treatmenttreats the signs of mild fungal nail infections

Timeline

Start date
2014-08-25
Primary completion
2014-11-21
Completion
2014-11-21
First posted
2015-09-10
Last updated
2017-04-11

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT02546258. Inclusion in this directory is not an endorsement.